On the evaluation of weak and reversible inhibitors of monoamine oxidase in vivo and in vitro. Investigations with diphenyl-piperidine derivatives.
D000470:Alkaloids / Q000378:metabolism; D000588:Amines / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D003641:Deamination; D066298:In Vitro Techniques; D007211:Indoles / Q000378:metabolism; D007527:Isoenzymes; D008099:Liver / Q000378:metabolism; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D014050:Toluene / Q000378:metabolism; D014363:Tryptamines / Q000378:metabolism
D000470:Alkaloids; D000588:Amines; D007211:Indoles; D007527:Isoenzymes; D008996:Monoamine Oxidase Inhibitors; D010880:Piperidines; D014363:Tryptamines; D014050:Toluene